These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
834 related articles for article (PubMed ID: 9003010)
1. Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts. Takahashi Y; Tobe K; Kadowaki H; Katsumata D; Fukushima Y; Yazaki Y; Akanuma Y; Kadowaki T Endocrinology; 1997 Feb; 138(2):741-50. PubMed ID: 9003010 [TBL] [Abstract][Full Text] [Related]
2. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells. Guvakova MA; Surmacz E Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways. Sasaoka T; Ishiki M; Sawa T; Ishihara H; Takata Y; Imamura T; Usui I; Olefsky JM; Kobayashi M Endocrinology; 1996 Oct; 137(10):4427-34. PubMed ID: 8828504 [TBL] [Abstract][Full Text] [Related]
4. Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling. Kim B; Cheng HL; Margolis B; Feldman EL J Biol Chem; 1998 Dec; 273(51):34543-50. PubMed ID: 9852124 [TBL] [Abstract][Full Text] [Related]
5. Modulation of insulin-like growth factor I mitogenic signaling in 3T3-L1 preadipocyte differentiation. Boney CM; Smith RM; Gruppuso PA Endocrinology; 1998 Apr; 139(4):1638-44. PubMed ID: 9528944 [TBL] [Abstract][Full Text] [Related]
6. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling. Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851 [TBL] [Abstract][Full Text] [Related]
7. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells. Kim B; Leventhal PS; White MF; Feldman EL Endocrinology; 1998 Dec; 139(12):4881-9. PubMed ID: 9832424 [TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor I synergizes with interleukin 4 for hematopoietic cell proliferation independent of insulin receptor substrate expression. Soon L; Flechner L; Gutkind JS; Wang LH; Baserga R; Pierce JH; Li W Mol Cell Biol; 1999 May; 19(5):3816-28. PubMed ID: 10207105 [TBL] [Abstract][Full Text] [Related]
9. Tyrosine phosphorylation-dependent and -independent role of Shc in the regulation of IGF-1-induced mitogenesis and glycogen synthesis. Sasaoka T; Ishiki M; Wada T; Hori H; Hirai H; Haruta T; Ishihara H; Kobayashi M Endocrinology; 2001 Dec; 142(12):5226-35. PubMed ID: 11713219 [TBL] [Abstract][Full Text] [Related]
10. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes. Mur C; Valverde AM; Kahn CR; Benito M Diabetes; 2002 Mar; 51(3):743-54. PubMed ID: 11872675 [TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: the roles of MAP kinase pathway and PI 3-kinase pathway. Kurihara S; Hakuno F; Takahashi S Endocr J; 2000 Dec; 47(6):739-51. PubMed ID: 11228049 [TBL] [Abstract][Full Text] [Related]
14. Functional importance of Shc tyrosine 317 on insulin signaling in Rat1 fibroblasts expressing insulin receptors. Ishihara H; Sasaoka T; Ishiki M; Takata Y; Imamura T; Usui I; Langlois WJ; Sawa T; Kobayashi M J Biol Chem; 1997 Apr; 272(14):9581-6. PubMed ID: 9083103 [TBL] [Abstract][Full Text] [Related]
15. Relative involvement of Shc tyrosine 239/240 and tyrosine 317 on insulin induced mitogenic signaling in rat1 fibroblasts expressing insulin receptors. Ishihara H; Sasaoka T; Wada T; Ishiki M; Haruta T; Usui I; Iwata M; Takano A; Uno T; Ueno E; Kobayashi M Biochem Biophys Res Commun; 1998 Nov; 252(1):139-44. PubMed ID: 9813159 [TBL] [Abstract][Full Text] [Related]
16. Functional importance of amino-terminal domain of Shc for interaction with insulin and epidermal growth factor receptors in phosphorylation-independent manner. Sasaoka T; Ishihara H; Sawa T; Ishiki M; Morioka H; Imamura T; Usui I; Takata Y; Kobayashi M J Biol Chem; 1996 Aug; 271(33):20082-7. PubMed ID: 8702728 [TBL] [Abstract][Full Text] [Related]
17. Formation of distinct signalling complexes involving phosphatidylinositol 3-kinase activity with stimulation of epidermal growth factor or insulin-like growth factor-I in human skin fibroblasts. Takahashi Y; Akanuma Y; Yazaki Y; Kadowaki T J Cell Physiol; 1999 Jan; 178(1):69-75. PubMed ID: 9886492 [TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor I receptor signaling in differentiation of neuronal H19-7 cells. Morrione A; Romano G; Navarro M; Reiss K; Valentinis B; Dews M; Eves E; Rosner MR; Baserga R Cancer Res; 2000 Apr; 60(8):2263-72. PubMed ID: 10786694 [TBL] [Abstract][Full Text] [Related]
19. Different pathways of postreceptor desensitization following chronic insulin treatment and in cells overexpressing constitutively active insulin receptors. Inoue G; Cheatham B; Kahn CR J Biol Chem; 1996 Nov; 271(45):28206-11. PubMed ID: 8910437 [TBL] [Abstract][Full Text] [Related]
20. Signalling pathways of insulin-like growth factor-I that are augmented by cAMP in FRTL-5 cells. Ariga M; Nedachi T; Akahori M; Sakamoto H; Ito Y; Hakuno F; Takahashi S Biochem J; 2000 Jun; 348 Pt 2(Pt 2):409-16. PubMed ID: 10816436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]